IL17A and psoriasis: This indicates that IL-19 and IL-24, rather than IL-22, IL-17A or IL-17F, were responsible for the late stage (day 10) keratinocyte hyper-proliferation and acanthosis in the IMQ-induced psoriasis mouse model during anti-IL-10 treatment.